1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 14, 1999
-------------
GISH BIOMEDICAL, INC.
(Exact name of Registrant as specified in its charter)
California 0-10728 95-3046028
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No)
2681 Kelvin Avenue, Irvine, California 92715
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (949) 756-5485
--------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Page 1 of 3
Exhibit Index on Page 3
2
ITEM 5. OTHER EVENTS
On June 14, 1999, the Company announced the resignation of Jeanne M.
Miller, the Company's Vice President and Chief Financial Officer. Ms. Miller is
resigning for personal and family reasons. The Company's management has
concluded its search for a new chief financial officer and expects to announce
Ms. Miller's successor shortly.
ITEM 7. EXHIBITS
EXHIBIT NO. DESCRIPTION
99.1 Press Release Dated June 14, 1999
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GISH BIOMEDICAL, INC.
Date: June 25, 1999 By: /s/ JEANNE M. MILLER
--------------------------------
Jeanne M. Miller
Chief Financial Officer
2 of 3
3
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
- ----------- -----------
99.1 Press Release dated June 14, 1999
3 of 3